Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis
Leonie C.S. De Vries(Amsterdam UMC Location University of Amsterdam), Wouter J. de Jonge(University of Bonn), Rabinder Prinjha(GlaxoSmithKline (United Kingdom)), Birgit Strobl(University of Veterinary Medicine Vienna), Pim J. Koelink(University of Amsterdam), Manon E. Wildenberg(Amsterdam UMC Location University of Amsterdam), Olaf Welting(Amsterdam UMC Location University of Amsterdam), Geert D’Haens(Amsterdam University Medical Centers), Inmaculada Rioja(Bicycle Therapeutics (United Kingdom)), Mohammed Ghiboub(Amsterdam UMC Location University of Amsterdam), Caroline Verseijden, Patricia H. P. van Hamersveld, Matthew Bell(GlaxoSmithKline (United Kingdom)), Mathias Müller(University of Veterinary Medicine Vienna)
Cited by 23
Related Papers
Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target
|The American Journal of Gastroenterology|2015|1.8k
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
|Nature Immunology|2005|1.1k
Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum
|Gastroenterology|1998|865